Metformin exhibits inhibitory effects on ferroptosis and alleviates chondrocyte metabolic imbalance in osteoarthritis models, as well as Erastin-induced ferroptosis, through the modulation of the P53/SLC7A11 pathway.
- DOI
- 10.1016/j.bcp.2025.116978
- Published
- 2025 Aug
- Container
- Biochemical pharmacology
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bcp.2025.116978,
title = {Metformin exhibits inhibitory effects on ferroptosis and alleviates chondrocyte metabolic imbalance in osteoarthritis models, as well as Erastin-induced ferroptosis, through the modulation of the P53/SLC7A11 pathway.},
author = {Jiaxin F and Xiang J and YongPing C and Kainan L and Tianjie X and Hui Z and Shiqing S and Cao Y and Qian W},
year = {2025},
journal = {Biochemical pharmacology},
doi = {10.1016/j.bcp.2025.116978},
url = {https://doi.org/10.1016/j.bcp.2025.116978}
}RIS
TY - JOUR TI - Metformin exhibits inhibitory effects on ferroptosis and alleviates chondrocyte metabolic imbalance in osteoarthritis models, as well as Erastin-induced ferroptosis, through the modulation of the P53/SLC7A11 pathway. AU - Jiaxin F AU - Xiang J AU - YongPing C AU - Kainan L AU - Tianjie X AU - Hui Z AU - Shiqing S AU - Cao Y AU - Qian W PY - 2025 JO - Biochemical pharmacology DO - 10.1016/j.bcp.2025.116978 UR - https://doi.org/10.1016/j.bcp.2025.116978 ER -
APA
F, J., J, X., C, Y., L, K., X, T., Z, H., S, S., Y, C., & W, Q. (2025). Metformin exhibits inhibitory effects on ferroptosis and alleviates chondrocyte metabolic imbalance in osteoarthritis models, as well as Erastin-induced ferroptosis, through the modulation of the P53/SLC7A11 pathway.. Biochemical pharmacology. https://doi.org/10.1016/j.bcp.2025.116978
Source records
- pubmed · retrieved 2026-09-26T22:42:34.231Z
- europe-pmc · retrieved 2026-09-26T22:42:34.238Z